Impact of induction intensity and transplantation on outcomes of patients with complex karyotype and TP53-mutated acute myeloid leukemia

被引：1
|
作者：
Jamy, Omer [1 ]
Diebold, Kendall [1 ]
Davis, Kenneth [2 ]
Bachiashvili, Kimo [1 ]
Rangaraju, Sravanti [1 ]
Vachhani, Pankit [1 ]
Godby, Kelly N. [1 ]
Salzman, Donna [1 ]
Bhatia, Ravi [1 ]
机构：
[1] Univ Alabama Birmingham, Div Hematol & Oncol, Dept Med, Birmingham, AL 35233 USA
[2] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 07期
关键词：
D O I：
10.1038/s41409-023-01977-7
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：823 / 825
页数：3
相关论文
共 50 条
  • [31] Outcomes with lower intensity therapy in TP53-mutated AML.
    Kadia, Tapan M.
    Boddu, Prajwal C.
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Borthakur, Gautam
    Andreeff, Michael
    Jabbour, Elias
    Dinardo, Courtney Denton
    Konopleva, Marina
    Daver, Naval Guastad
    Takahashi, Koichi
    Patel, Keyur
    Kanagal-Shamanna, Rashmi
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] Prognostic Impact of Chromosomal Abnormalities in TP53-Mutated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes
    Takeda, June
    Iwasaki, Makoto
    Kanda, Junya
    Nannya, Yasuhito
    Hiramoto, Nobuhiro
    Kondo, Tadakazu
    Ishikawa, Takayuki
    Watanabe, Mitsumasa
    Kawata, Takahito
    Maeda, Takeshi
    Ueda, Yasunori
    Imada, Kazunori
    Kitano, Toshiyuki
    Tsuji, Masaaki
    Maesako, Yoshitomo
    Oka, Satoko
    Tanaka, Yasuhiro
    Miyoshi, Takashi
    Asagoe, Kosuke
    Itoh, Mitsuru
    Hirata, Hirokazu
    Kawabata, Hiroshi
    Hishizawa, Masakatsu
    Maeda, Akinori
    Yago, Kazuhiro
    Sasaki, Nana
    Uoshima, Nobuhiko
    Ogawa, Seishi
    Takaori-Kondo, Akifumi
    BLOOD, 2023, 142
  • [33] TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Current Guidelines, Therapies, and Future Considerations
    DiGennaro, Jeremy
    Sallman, David A.
    ACTA HAEMATOLOGICA, 2024, 147 (02) : 176 - 186
  • [34] TP53 mutated acute myeloid leukemia
    Sill, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 257 - 257
  • [35] Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin
    Wang, Yin
    Liu, Yan
    Bailey, Christopher
    Zhang, Huixia
    He, Miao
    Sun, Duxin
    Zhang, Peng
    Parkin, Brian
    Baer, Maria R.
    Zheng, Pan
    Malek, Sami N.
    Liu, Yang
    ONCOGENE, 2020, 39 (14) : 3015 - 3027
  • [36] The Current Understanding of and Treatment Paradigm for Newly-Diagnosed TP53-Mutated Acute Myeloid Leukemia
    Shallis, Rory M.
    Stahl, Maximilian
    Bewersdorf, Jan Philipp
    Zeidan, Amer M.
    Testa, Ugo
    Walter, Roland B.
    HEMATO, 2021, 2 (04): : 748 - 763
  • [37] TP53-mutated acute myeloid leukemia and myelodysplastic syndrome: biology, treatment challenges, and upcoming approaches
    Pereira, Mariana Pinto
    Herrity, Elizabeth
    Kim, Dennis D. H.
    ANNALS OF HEMATOLOGY, 2024, 103 (04) : 1049 - 1067
  • [38] Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin
    Yin Wang
    Yan Liu
    Christopher Bailey
    Huixia Zhang
    Miao He
    Duxin Sun
    Peng Zhang
    Brian Parkin
    Maria R. Baer
    Pan Zheng
    Sami N. Malek
    Yang Liu
    Oncogene, 2020, 39 : 3015 - 3027
  • [39] TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions
    Daver, Naval G.
    Maiti, Abhishek
    Kadia, Tapan M.
    Vyas, Paresh
    Majeti, Ravindra
    Wei, Andrew H.
    Garcia-Manero, Guillermo
    Craddock, Charles
    Sallman, David A.
    Kantarjian, Hagop M.
    CANCER DISCOVERY, 2022, 12 (11) : 2516 - 2529
  • [40] TP53-mutated acute myeloid leukemia and myelodysplastic syndrome: biology, treatment challenges, and upcoming approaches
    Mariana Pinto Pereira
    Elizabeth Herrity
    Dennis D.H Kim
    Annals of Hematology, 2024, 103 : 1049 - 1067
12345